149 related articles for article (PubMed ID: 19903812)
1. Proline is not uniquely capable of providing the pivot point for domain swapping in 2G12, a broadly neutralizing antibody against HIV-1.
Gach JS; Furtmüller PG; Quendler H; Messner P; Wagner R; Katinger H; Kunert R
J Biol Chem; 2010 Jan; 285(2):1122-7. PubMed ID: 19903812
[TBL] [Abstract][Full Text] [Related]
2. Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged.
Doores KJ; Fulton Z; Huber M; Wilson IA; Burton DR
J Virol; 2010 Oct; 84(20):10690-9. PubMed ID: 20702629
[TBL] [Abstract][Full Text] [Related]
3. Very few substitutions in a germ line antibody are required to initiate significant domain exchange.
Huber M; Le KM; Doores KJ; Fulton Z; Stanfield RL; Wilson IA; Burton DR
J Virol; 2010 Oct; 84(20):10700-7. PubMed ID: 20702640
[TBL] [Abstract][Full Text] [Related]
4. The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.
Scanlan CN; Pantophlet R; Wormald MR; Ollmann Saphire E; Stanfield R; Wilson IA; Katinger H; Dwek RA; Rudd PM; Burton DR
J Virol; 2002 Jul; 76(14):7306-21. PubMed ID: 12072529
[TBL] [Abstract][Full Text] [Related]
5. 2G12-expressing B cell lines may aid in HIV carbohydrate vaccine design strategies.
Doores KJ; Huber M; Le KM; Wang SK; Doyle-Cooper C; Cooper A; Pantophlet R; Wong CH; Nemazee D; Burton DR
J Virol; 2013 Feb; 87(4):2234-41. PubMed ID: 23221565
[TBL] [Abstract][Full Text] [Related]
6. An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing human immunodeficiency virus type 1 antibody 2G12 and elicits mannose-specific gp120-binding antibodies.
Luallen RJ; Lin J; Fu H; Cai KK; Agrawal C; Mboudjeka I; Lee FH; Montefiori D; Smith DF; Doms RW; Geng Y
J Virol; 2008 Jul; 82(13):6447-57. PubMed ID: 18434410
[TBL] [Abstract][Full Text] [Related]
7. A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120.
Astronomo RD; Lee HK; Scanlan CN; Pantophlet R; Huang CY; Wilson IA; Blixt O; Dwek RA; Wong CH; Burton DR
J Virol; 2008 Jul; 82(13):6359-68. PubMed ID: 18434393
[TBL] [Abstract][Full Text] [Related]
8. Expression, glycoform characterization, and antibody-binding of HIV-1 V3 glycopeptide domain fused with human IgG1-Fc.
Yang Q; Li C; Wei Y; Huang W; Wang LX
Bioconjug Chem; 2010 May; 21(5):875-83. PubMed ID: 20369886
[TBL] [Abstract][Full Text] [Related]
9. A yeast glycoprotein shows high-affinity binding to the broadly neutralizing human immunodeficiency virus antibody 2G12 and inhibits gp120 interactions with 2G12 and DC-SIGN.
Luallen RJ; Fu H; Agrawal-Gamse C; Mboudjeka I; Huang W; Lee FH; Wang LX; Doms RW; Geng Y
J Virol; 2009 May; 83(10):4861-70. PubMed ID: 19264785
[TBL] [Abstract][Full Text] [Related]
10. Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12.
Calarese DA; Lee HK; Huang CY; Best MD; Astronomo RD; Stanfield RL; Katinger H; Burton DR; Wong CH; Wilson IA
Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13372-7. PubMed ID: 16174734
[TBL] [Abstract][Full Text] [Related]
11. High temperature SELMA: evolution of DNA-supported oligomannose clusters which are tightly recognized by HIV bnAb 2G12.
Temme JS; MacPherson IS; DeCourcey JF; Krauss IJ
J Am Chem Soc; 2014 Feb; 136(5):1726-9. PubMed ID: 24446826
[TBL] [Abstract][Full Text] [Related]
12. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus.
Liao HX; Lynch R; Zhou T; Gao F; Alam SM; Boyd SD; Fire AZ; Roskin KM; Schramm CA; Zhang Z; Zhu J; Shapiro L; ; Mullikin JC; Gnanakaran S; Hraber P; Wiehe K; Kelsoe G; Yang G; Xia SM; Montefiori DC; Parks R; Lloyd KE; Scearce RM; Soderberg KA; Cohen M; Kamanga G; Louder MK; Tran LM; Chen Y; Cai F; Chen S; Moquin S; Du X; Joyce MG; Srivatsan S; Zhang B; Zheng A; Shaw GM; Hahn BH; Kepler TB; Korber BT; Kwong PD; Mascola JR; Haynes BF
Nature; 2013 Apr; 496(7446):469-76. PubMed ID: 23552890
[TBL] [Abstract][Full Text] [Related]
13. Antibody recognition of HIV and dengue glycoproteins.
Krauss IJ
Glycobiology; 2016 Aug; 26(8):813-9. PubMed ID: 26941393
[TBL] [Abstract][Full Text] [Related]
14. A solution NMR study of the interactions of oligomannosides and the anti-HIV-1 2G12 antibody reveals distinct binding modes for branched ligands.
Enríquez-Navas PM; Marradi M; Padro D; Angulo J; Penadés S
Chemistry; 2011 Feb; 17(5):1547-60. PubMed ID: 21268157
[TBL] [Abstract][Full Text] [Related]
15. Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4-binding site neutralizing antibodies.
Rathore U; Purwar M; Vignesh VS; Das R; Kumar AA; Bhattacharyya S; Arendt H; DeStefano J; Wilson A; Parks C; La Branche CC; Montefiori DC; Varadarajan R
J Biol Chem; 2018 Sep; 293(39):15002-15020. PubMed ID: 30093409
[TBL] [Abstract][Full Text] [Related]
16. Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein.
Moore JP; Sodroski J
J Virol; 1996 Mar; 70(3):1863-72. PubMed ID: 8627711
[TBL] [Abstract][Full Text] [Related]
17. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.
Sanders RW; Venturi M; Schiffner L; Kalyanaraman R; Katinger H; Lloyd KO; Kwong PD; Moore JP
J Virol; 2002 Jul; 76(14):7293-305. PubMed ID: 12072528
[TBL] [Abstract][Full Text] [Related]
18. Visualization of retroviral envelope spikes in complex with the V3 loop antibody 447-52D on intact viruses by cryo-electron tomography.
Dutta M; Liu J; Roux KH; Taylor KA
J Virol; 2014 Nov; 88(21):12265-75. PubMed ID: 25122783
[TBL] [Abstract][Full Text] [Related]
19. Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody.
Lee HK; Scanlan CN; Huang CY; Chang AY; Calarese DA; Dwek RA; Rudd PM; Burton DR; Wilson IA; Wong CH
Angew Chem Int Ed Engl; 2004 Feb; 43(8):1000-3. PubMed ID: 14966891
[No Abstract] [Full Text] [Related]
20. Kinetic mechanism for HIV-1 neutralization by antibody 2G12 entails reversible glycan binding that slows cell entry.
Platt EJ; Gomes MM; Kabat D
Proc Natl Acad Sci U S A; 2012 May; 109(20):7829-34. PubMed ID: 22547820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
